<unk>  is a calcitonin gene-related peptide antagonist that is FDA approved for the preventive treatment of migraine in adults.   Common adverse reactions include injection site reactions.
Fremanezumab-vfrm
Galcanezumab-gnlm
Tisotumab vedotin-tftv
Cemiplimab-rwlc
Ustekinumab
Lanadelumab
Blinatumomab
Moxetumomab pasudotox-tdfk